Advertisement

Index by Author

June 1995; 44 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abumrad, N N

    • Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes June 1995 44:672-681; doi:10.2337/diabetes.44.6.672

  2. Akselsen, H E

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

  3. Alper, C A

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  4. Aoki, M

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  5. Awdeh, Z L

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  6. Azevedo, J L, Jr

    • Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:682-688; doi:10.2337/diabetes.44.6.682
    • Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:695-698; doi:10.2337/diabetes.44.6.695

B

  1. Behme, M T

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

  2. Bell, G I

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  3. Bennett, S T

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

  4. Berti, L

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  5. Bonifacio, E

    • Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. Diabetes June 1995 44:636-640; doi:10.2337/diabetes.44.6.636

  6. Bossenmaier, B

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  7. Brunel, P

    • Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes June 1995 44:631-635; doi:10.2337/diabetes.44.6.631

  8. Byrne, M M

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

C

  1. Canessa, M L

    • Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes June 1995 44:665-671; doi:10.2337/diabetes.44.6.665

  2. Carey, J O

    • Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:682-688; doi:10.2337/diabetes.44.6.682
    • Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:695-698; doi:10.2337/diabetes.44.6.695

  3. Cherrington, A D

    • Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes June 1995 44:672-681; doi:10.2337/diabetes.44.6.672

  4. Coates, P A

    • Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes June 1995 44:631-635; doi:10.2337/diabetes.44.6.631

  5. Colman, P G

    • Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. Diabetes June 1995 44:636-640; doi:10.2337/diabetes.44.6.636

  6. Cooney, G J

    • Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes June 1995 44:718-720; doi:10.2337/diabetes.44.6.718

D

  1. DeFronzo, R A

    • Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes June 1995 44:665-671; doi:10.2337/diabetes.44.6.665

  2. Delovitch, T L

    • Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes June 1995 44:614-619; doi:10.2337/diabetes.44.6.614

  3. Dohm, G L

    • Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:682-688; doi:10.2337/diabetes.44.6.682
    • Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:695-698; doi:10.2337/diabetes.44.6.695

  4. Dupre, J

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

E

  1. Eisenbarth, G S

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  2. Erlich, H A

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

F

  1. Fajans, S S

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  2. Ferrer, J

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  3. Foulis, A

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  4. Froguel, P

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  5. Fujiwara, T

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

G

  1. Galante, P

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  2. Gianani, R

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  3. Gill, B M

    • Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes June 1995 44:614-619; doi:10.2337/diabetes.44.6.614

  4. Giordano, M

    • Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes June 1995 44:665-671; doi:10.2337/diabetes.44.6.665

  5. Goddard, A

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  6. Goldstein, R E

    • Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes June 1995 44:672-681; doi:10.2337/diabetes.44.6.672

H

  1. Halter, J B

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  2. Hara, T

    • Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes June 1995 44:718-720; doi:10.2337/diabetes.44.6.718

  3. Häring, H U

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  4. Hiltunen, M

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  5. Horikoshi, H

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  6. Hovi, T

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  7. Hramiak, I M

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

  8. Huang, X

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  9. Hyöty, H

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

I

  1. Ikäheimo, I

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

J

  1. Jackson, R A

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  2. James, R F

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  3. Jaramillo, A

    • Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes June 1995 44:614-619; doi:10.2337/diabetes.44.6.614

  4. Jéquier, E

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

K

  1. Karjalainen, J

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  2. Kellerer, M

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  3. Knip, M

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620
    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  4. Kohner, E M

    • Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes June 1995 44:603-607; doi:10.2337/diabetes.44.6.603

  5. Koskela, P

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  6. Kusunoki, M

    • Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes June 1995 44:718-720; doi:10.2337/diabetes.44.6.718

L

  1. Laakkonen, M

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  2. Lacy, D B

    • Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes June 1995 44:672-681; doi:10.2337/diabetes.44.6.672

  3. Laupland, K B

    • Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes June 1995 44:614-619; doi:10.2337/diabetes.44.6.614

  4. Leinikki, P

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  5. Lernmark, A

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  6. Luzio, S D

    • Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes June 1995 44:631-635; doi:10.2337/diabetes.44.6.631

M

  1. Ma, L

    • Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes June 1995 44:614-619; doi:10.2337/diabetes.44.6.614

  2. Matsuda, M

    • Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes June 1995 44:665-671; doi:10.2337/diabetes.44.6.665

  3. McDonald, T J

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

  4. McFarlane, P

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

  5. Moromisato, R

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  6. Morris, P G

    • Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:682-688; doi:10.2337/diabetes.44.6.682
    • Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:695-698; doi:10.2337/diabetes.44.6.695

  7. Mosthaf, L

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

N

  1. Nicod, P

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

O

  1. Okuno, A

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  2. Ortiz, F J

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  3. Owens, D R

    • Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes June 1995 44:631-635; doi:10.2337/diabetes.44.6.631

  4. Owlya, R

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

P

  1. Patel, V

    • Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes June 1995 44:603-607; doi:10.2337/diabetes.44.6.603

  2. Permutt, M A

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  3. Polonsky, K S

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699
    • Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes June 1995 44:705-717; doi:10.2337/diabetes.44.6.705

  4. Pories, W J

    • Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:682-688; doi:10.2337/diabetes.44.6.682
    • Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes June 1995 44:695-698; doi:10.2337/diabetes.44.6.695

  5. Pugliese, A

    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes June 1995 44:608-613; doi:10.2337/diabetes.44.6.608

  6. Pujol-Borrell, R

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

R

  1. Rabin, D U

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  2. Rabinovitch, A

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  3. Rassam, S M

    • Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes June 1995 44:603-607; doi:10.2337/diabetes.44.6.603

  4. Reijonen, H

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

  5. Riggs, A C

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  6. Roivainen, M

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  7. Rønningen, K S

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

S

  1. Sanders, L

    • Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes June 1995 44:665-671; doi:10.2337/diabetes.44.6.665

  2. Scherrer, U

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

  3. Schmidli, R S

    • Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop. Diabetes June 1995 44:636-640; doi:10.2337/diabetes.44.6.636

  4. Smith, M J

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  5. Somoza, N

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  6. Stewart, T A

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

  7. Stoffel, M

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  8. Stoltz, A

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

  9. Storlien, L H

    • Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes June 1995 44:718-720; doi:10.2337/diabetes.44.6.718

  10. Sturis, J

    • Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes June 1995 44:699-704; doi:10.2337/diabetes.44.6.699

T

  1. Tanizawa, Y

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  2. Tappy, L

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

  3. Thorsby, E

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

  4. Tippmer, S

    • Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle. Diabetes June 1995 44:646-651; doi:10.2337/diabetes.44.6.646

  5. Todd, J A

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

U

  1. Undlien, D E

    • Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene. Diabetes June 1995 44:620-625; doi:10.2337/diabetes.44.6.620

V

  1. Vähäsalo, P

    • A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes June 1995 44:652-657; doi:10.2337/diabetes.44.6.652

  2. Vaxillaire, M

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  3. Vollenweider, L

    • Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes June 1995 44:641-645; doi:10.2337/diabetes.44.6.641

W

  1. Wasserman, D H

    • Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency. Diabetes June 1995 44:672-681; doi:10.2337/diabetes.44.6.672

  2. Wasson, J

    • Characterization of the LIM/homeodomain gene islet-1 and single nucleotide screening in NIDDM. Diabetes June 1995 44:689-694; doi:10.2337/diabetes.44.6.689

  3. Williamson, M P

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

Y

  1. Yuang, J

    • Interferon expression in the pancreases of patients with type I diabetes. Diabetes June 1995 44:658-664; doi:10.2337/diabetes.44.6.658

Z

  1. Zabel, P

    • Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes June 1995 44:626-630; doi:10.2337/diabetes.44.6.626

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement